| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 75.360.236 $ | +34.624.236 $ | +43,4 % | 16 | 46.249.800 $ | +46.249.800 $ | 9 | |||||
| Praxis Precision Medicines, Inc. | PRAX | → 0 | Schwach | 13.870.280 $ | +2.080.680 $ | +17,6 % | 1 | 11.789.600 $ | +11.789.600 $ | 1 | |
| Axsome Therapeutics, Inc. | AXSM | → 0 | Schwach | 6.929.820 $ | +6.929.820 $ | 1 | |||||
| Xeris Biopharma Holdings, Inc. | XERS | → 0 | Neutral | 5.945.000 $ | -335.000 $ | -5,3 % | 1 | 6.280.000 $ | +6.280.000 $ | 1 | |
| BIOMARIN PHARMACEUTICAL INC | BMRN | → 0 | Stark | 4.632.180 $ | -1.310.820 $ | -22,1 % | 1 | 5.943.000 $ | +5.943.000 $ | 1 | |
| KalVista Pharmaceuticals, Inc. | KALV | → 0 | 5.570.978 $ | +5.570.978 $ | 1 | ||||||
| AMICUS THERAPEUTICS, INC. | FOLD | → 0 | 5.335.740 $ | +209.340 $ | +4,1 % | 1 | 5.126.400 $ | +5.126.400 $ | 1 | ||
| Verastem, Inc. | VSTM | → 0 | Schwach | 4.346.000 $ | +2.261.600 $ | +108,5 % | 1 | ||||
| ACADIA PHARMACEUTICALS INC | ACAD | → 0 | Stark | 2.737.980 $ | -1.535.620 $ | -35,9 % | 1 | 4.273.600 $ | +4.273.600 $ | 1 | |
| Annexon, Inc. | ANNX | → 0 | Schwach | 3.765.000 $ | +3.765.000 $ | 1 | |||||
| Ultragenyx Pharmaceutical Inc. | RARE | → 0 | Neutral | 3.650.538 $ | +2.500.538 $ | +217,4 % | 1 | ||||
| Nuvation Bio Inc. | NUVB | → 0 | Neutral | 3.584.000 $ | +3.584.000 $ | 1 | |||||
| ARROWHEAD PHARMACEUTICALS, INC. | ARWR | → 0 | Neutral | 3.470.445 $ | +3.470.445 $ | 1 | |||||
| Vaxcyte, Inc. | PCVX | → 0 | Neutral | 3.335.514 $ | +1.028.514 $ | +44,6 % | 1 | ||||
| Vera Therapeutics, Inc. | VERA | → 0 | Neutral | 3.298.860 $ | +3.298.860 $ | 1 | |||||
| Travere Therapeutics, Inc. | TVTX | → 0 | Schwach | 3.288.897 $ | +3.288.897 $ | 1 | |||||
| MoonLake Immunotherapeutics | MLTX | → 0 | Schwach | 3.248.020 $ | +3.248.020 $ | 1 | |||||
| Zentalis Pharmaceuticals, Inc. | ZNTL | → 0 | Neutral | 2.878.200 $ | +1.096.200 $ | +61,5 % | 1 | ||||
| Scholar Rock Holding Corp | SRRK | → 0 | Neutral | 2.821.784 $ | +2.821.784 $ | 1 | |||||
| BridgeBio Pharma, Inc. | BBIO | → 0 | Sehr schwach | 2.753.640 $ | +2.753.640 $ | 1 | |||||
| PTC THERAPEUTICS, INC. | PTCT | → 0 | Neutral | 2.734.560 $ | +2.734.560 $ | 1 | |||||
| 75.360.236 $ | +34.624.236 $ | +43,4 % | 16 | 46.249.800 $ | +46.249.800 $ | 9 | |||||